Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-12-28
|
pubmed:abstractText |
Prophylactic drug treatment is one of several strategies to reduce postoperative blood loss and potentially limit homologous blood use in open heart surgery. A computerized MEDLINE search supplemented with manual bibliography reviews was performed for randomized clinical trials published in peer-reviewed English-language journals from January 1980 to June 1993. A metaanalysis was conducted of trials evaluating desmopressin (group DD, n = 13), epsilon-aminocaproic acid or tranexamic acid (group EA, n = 4), and aprotinin (group AP, n = 16). Eligible studies used placebo controls and administered the drug in a prophylactic manner. The primary study end point was postoperative chest tube loss (mL, mean +/- standard deviation). There was a significant reduction in postoperative chest tube loss detected for each of the active treatments versus the placebo (DD versus controls: percent reduction 0.11, p = 0.0021; EA versus controls: percent reduction 0.30, p < 0.0001; and AP versus controls: percent reduction 0.36, p < 0.0001). Therapy with EA or AP was associated with a greater reduction in chest tube loss than DD (EA versus DD, p = 0.0033, and AP versus DD, p < 0.0001). Secondary study end points were transfusion requirements, chest reexploration, and perioperative mortality. The volume of postoperative red cell transfusion (mean +/- standard deviation) was reduced with EA (p < 0.0001) or AP treatment (p < 0.0001) compared with a placebo or DD, whereas the proportion of patients given transfusions was limited only in the AP-treated patients (odds ratio 0.23; 95% confidence interval, 0.16 to 0.33; p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/6-Aminocaproic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Aprotinin,
http://linkedlifedata.com/resource/pubmed/chemical/Deamino Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemostatics,
http://linkedlifedata.com/resource/pubmed/chemical/Tranexamic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1580-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7526811-6-Aminocaproic Acid,
pubmed-meshheading:7526811-Aprotinin,
pubmed-meshheading:7526811-Blood Loss, Surgical,
pubmed-meshheading:7526811-Cardiac Surgical Procedures,
pubmed-meshheading:7526811-Coronary Artery Bypass,
pubmed-meshheading:7526811-Deamino Arginine Vasopressin,
pubmed-meshheading:7526811-Hemostatics,
pubmed-meshheading:7526811-Humans,
pubmed-meshheading:7526811-Postoperative Complications,
pubmed-meshheading:7526811-Premedication,
pubmed-meshheading:7526811-Tranexamic Acid
|
pubmed:year |
1994
|
pubmed:articleTitle |
Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.
|
pubmed:affiliation |
Department of Anaesthesia, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|